A Phase 1 interventional study of GL2702 GLARS-NF1 and Omix Ocas in Healthy, sponsored by GL Pharm Tech Corporation. Completed at 1 site in Korea, Republic of. Open to male participants aged 20 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-01-10.
Sponsored by GL Pharm Tech Corporation · Phase 1, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Study to Investigate The Pharmacokinetics of GL2702 GLARS-NF1 and Omix Ocas® in Healthy Male Volunteers
GL2702 GLARS-NF1 tablet is controlled released formulation which is invented by GL Pharm Tech Corp.
GL Pharm Tech Corporation is the lead sponsor of 16 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Two enzymes measured in a routine blood test of the liver. Higher levels can mean the liver is under strain or damaged. SGPT and SGOT are older names for ALT and AST.
Criteria usually give a limit as a multiple of the upper limit of normal (ULN), often higher when cancer has spread to the liver.
A yellow substance made when red blood cells are broken down, which the liver clears. A high level can mean a problem with the liver or the bile ducts.
Criteria often allow more for people with Gilbert’s syndrome, a harmless inherited condition that raises bilirubin.
ALT and AST (liver enzymes)
Two enzymes measured in a routine blood test of the liver. Higher levels can mean the liver is under strain or damaged. SGPT and SGOT are older names for ALT and AST.
Criteria usually give a limit as a multiple of the upper limit of normal (ULN), often higher when cancer has spread to the liver.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Bilirubin
A yellow substance made when red blood cells are broken down, which the liver clears. A high level can mean a problem with the liver or the bile ducts.
Criteria often allow more for people with Gilbert’s syndrome, a harmless inherited condition that raises bilirubin.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Tamsulsoin 0.4mg
Drug: GL2702 GLARS-NF1
Tamsulsoin 0.4mg
Drug: Omix Ocas
Tamsulsoin 0.4mg
Drug: GL2702 GLARS-NF1
Tamsulsoin 0.4mg
Drug: Omix Ocas
0.4mg once a day
Also known as: Tamsulosin
0.4mg once a day
Also known as: Tamsulosin
Cmax
Pharmacokinetic parameter of tamsulosin 0.4mg
Time frame: 48 hours
AUClast
Pharmacokinetic parameter of Tamsulosin 0.4mg
Time frame: 48 hours
Tmax
Pharmacokinetic parameter of Tamsulosin 0.4 mg
Time frame: 48 hours
t1/2
Pharmacokinetic parameter of Tamsulosin 0.4 mg
Time frame: 48 hours
Vz/F
Pharmacokinetic parameter of Tamsulosin 0.4 mg
Time frame: 48 hours
CL/F
Pharmacokinetic parameter of Tamsulosin 0.4 mg
Time frame: 48 hours
The record gives a start of Aug 2013, a primary completion of Jan 2014 and a completion of Jan 2014. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Feb 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Tamsulosin
GL Pharm Tech Corporation